MedPath

Does the medication 'tranexamic acid' decrease pain and improve function in the short term after arthroscopic meniscectomy?

Phase 4
Recruiting
Conditions
Arthroscopic meniscectomy for meniscal tear
Musculoskeletal - Other muscular and skeletal disorders
Registration Number
ACTRN12618001600235
Lead Sponsor
Prof Gary Hooper
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
40
Inclusion Criteria

Patients undergoing elective arthroscopic meniscectomy for meniscal tear(s)

Exclusion Criteria

Previous reconstructive surgery on the same knee
Known clotting disorders
Known renal impairment
Known allergy to tranexamic acid

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath